Enhanced phosphorylation of p53 serine 18 following DNA damage in DNA-dependent protein kinase catalytic subunit-deficient cells.

DNA-dependent protein kinase (DNA-PK) controls signal transduction following DNA damage. However, the molecular mechanism of the signal transduction has been elusive. A number of candidates for substrates of DNA-PK have been reported on the basis of the in vitro assay system. In particular, the Ser-15 amino acid residue in p53 was one of the first such in vitro substrates to be described, and it has drawn considerable attention due to its biological significance. Moreover, p53 Ser-15 is a site that has been shown to be phosphorylated in response to DNA damage. In addition, crucial evidence indicating that DNA-PK controls the transactivation of p53 following DNA damage was reported quite recently. To clarify these important issues, we conducted the experiments with dna-pkcs null mutant cells, including gene knockout cells. As a result, we detected enhanced phosphorylation of p53 Ser-18, which corresponds to Ser-15 of human p53, and significant expression of p21 and mdm2 following ionizing radiation. Furthermore, we identified a missense point mutation in the p53 DNA-binding motif region in SCGR11 cells, which were established from severe combined immunodeficient (SCID) mice and used for previous study on the role of DNA-PK in p53 transactivation. Our observation clearly indicates that DNA-PK catalytic subunit does not phosphorylate p53 Ser-18 in vivo or control the transactivation of p53 in response to DNA damage, and these results further emphasize the different pathways in which ataxia telangiectasia-mutated (ATM) and DNA-PK operate following radiation damage.

[1]  T. Saito,et al.  Nonsense mutation at Tyr-4046 in the DNA-dependent protein kinase catalytic subunit of severe combined immune deficiency mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Derrick E. Rancourt,et al.  DNA-dependent protein kinase acts upstream of p53 in response to DNA damage , 1998, Nature.

[3]  D. Chan,et al.  Lack of correlation between ATM protein expression and tumour cell radiosensitivity. , 1998, International journal of radiation biology.

[4]  H. Hama-Inaba,et al.  X-ray-sensitive mutants of mouse mammary carcinoma cells are hypersensitive to bleomycin and hydrogen peroxide. , 1986, Japanese journal of cancer research : Gann.

[5]  H. Koyama,et al.  Adenine phosphoribosyltransferase deficiency in cultured mouse mammary tumor FM3A cells resistant to 4-carbamoylimidazolium 5-olate. , 1982, Cancer research.

[6]  M. Bogue,et al.  Analysis of variable (diversity) joining recombination in DNAdependent protein kinase (DNA-PK)-deficient mice reveals DNA-PK-independent pathways for both signal and coding joint formation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Y Taya,et al.  DNA damage induces phosphorylation of the amino terminus of p53. , 1997, Genes & development.

[8]  D. Schatz,et al.  A link between double-strand break-related repair and V(D)J recombination: the scid mutation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R. Fleischmann,et al.  DNA-PKcs: a T-cell tumour suppressor encoded at the mouse scid locus , 1997, Nature Genetics.

[10]  Yoichi Taya,et al.  DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2 , 1997, Cell.

[11]  R. Fukumura,et al.  Murine Cell Line SX9 Bearing a Mutation in the dna-pkcsGene Exhibits Aberrant V(D)J Recombination Not Only in the Coding Joint but Also in the Signal Joint* , 1998, The Journal of Biological Chemistry.

[12]  Y Taya,et al.  Enhanced phosphorylation of p53 by ATM in response to DNA damage. , 1998, Science.

[13]  C. Anderson,et al.  DNA damage and the DNA-activated protein kinase. , 1993, Trends in biochemical sciences.

[14]  P. Jeggo,et al.  Targeted disruption of the catalytic subunit of the DNA-PK gene in mice confers severe combined immunodeficiency and radiosensitivity. , 1998, Immunity.

[15]  C. Kemp,et al.  p53 induction, cell cycle checkpoints, and apoptosis in DNAPK-deficient scid mice. , 1996, Carcinogenesis.

[16]  C. Cordon-Cardo,et al.  Catalytic subunit of DNA-dependent protein kinase: impact on lymphocyte development and tumorigenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D. J. Chen,et al.  Interspecific complementation between mouse and Chinese hamster cell mutants hypersensitive to ionizing radiation. , 1995, Journal of radiation research.

[18]  G. Chu,et al.  DNA-dependent protein kinase is not required for accumulation of p53 or cell cycle arrest after DNA damage. , 1997, Cancer research.

[19]  Y Taya,et al.  Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. , 1998, Science.

[20]  H. Koyama,et al.  Adenine Phosphoribosyltransferase Deficiency Tumor FM3A Cells Resistant to 4-Carbamoylimidazolium 5-Olate , 1982 .

[21]  T. Jacks,et al.  Mutations in the p53 and SCID genes cooperate in tumorigenesis. , 1996, Genes & development.

[22]  G. Wahl,et al.  p53-dependent cell cycle arrests are preserved in DNA-activated protein kinase-deficient mouse fibroblasts. , 1996, Cancer research.